ddt 16 Flashcards
(45 cards)
an antibiotic that hasn’t been used in clinics beadier but belonging to class of antibiotics
new antibiotics
an antibiotics w mechanism of action never used against bacteria
novel antibiotics
infections are mostly associated w
invasive medical devices and surgical procedures
S.aureus produces
4 enzymes ( peniclin binding proteins PBP ) for cell wall biosynthesis
PBP 1-4 can be modified by
b-lactam antibiotics leading to their inhibition and bacterial death
MRSA produced —- which is not inhibited by— and can produce all functions of —-
- altered PBP. (PBP2a)
- b- lactam
- all 4 PBP of S aueures.
the production of altered PBP is considered to be
recent resistance mechanism in gram +ve compared to the b-lactamase is ancient evolutionary
Treatment of infection caused by MRSA
- antibiotics other than penicillin/ b- lactam
( almost 50% of mrsa strains r resistant to all but few antibiotics ) - vancomycin destroys mrsa and resistant bacteria
( first case was VRSA and there are 52 VRSA strains )
novel antibiotics for mrsa treatments
- linezoid ( oxazolidinone )
- synercid ( combination of streptograms, quinupristin, dalfopristin )
- daptomycin ( lipopeptide )
linezolid is a
oxazolidinone class of antibiotics
linezoilds works for —- by inhibiting —- in only gram — bacteria
mrsa and VRE , inhibition of protein synthesis , gram +ve only
intravenous treatment caused by VRE, staph. aureus, and strep. pyogen
Synercid by inhibiting protein synthesis both agents at same place in the ribosome
—– when administered individually and —- when in combination
bacteriostatic, synerically and becomes bactericidal
intravenous treatment of gram +ve infections by binding to cell membrane and causes depolarisation
daptomycin ( cubcin )
- it interrupts protein, dna and rna sythesis
- slow emerges of resistance in clinic
patient being hostiblized for prolonged period of times and receiving multible course of antibiotics results in
antibiotic resistance
enterococcus faecalis and enterococcus fascium are
more difficult to treat and higher incidence of resistance against vancomycin ( 15-20% of isolates )
32 before emerges requires — genes mutation for resistance against vancomycin but 2-3 years against penicillin requires — mutation
5 genes , 1 gene
vancomycin works by
inhibiting the cell wall beiosystheis and block the substrate while peciline blocks the enzyme
is a glycopeptide antibiotic
vancomycin
bacteria becomes resistant when
- loss of a single hydrogen bond = 1,000 folds drop in drug binding affinity ( from D-Ala to D- Lac )
Clostridium difficile associated diseases ( CDAD)
- gram +ve
- requires anaerobic bacterium
- spores forming
- toxigenic strains: toxins A + B causes extensive damage to colonic mucosa
—- causes major nosocomial diarrhoea
CDAD
more than — produced — and — antibiotic treatment
90% after and during
treatments of CDAD includes
1- medical therapy includes discontinuation of inciting antibiotic if possible
2- specific antibiotic treatment if persisent diarrhoea:
- metrazodiale at first line antibtioc agent
- vancomycin as alternate agent for 2nd line therapy
- both are taken orally